<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="androgen" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">androgen</book-part-id>
      <title-group>
        <title>Androgen Insensitivity Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Testicular Feminization</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gottlieb</surname>
            <given-names>Bruce</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="androgen.Tc.aff1"/>
          <xref ref-type="aff" rid="androgen.Tc.aff2"/>
          <email>bruce.gottlieb@mcgill.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Trifiro</surname>
            <given-names>Mark A</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="androgen.Tc.aff3"/>
          <xref ref-type="aff" rid="androgen.Tc.aff4"/>
          <email>mark.trifiro@mcgill.ca</email>
        </contrib>
      </contrib-group>
      <aff id="androgen.Tc.aff1">Lady Davis Institute for Medical Research <break/>Jewish General Hospital</aff>
      <aff id="androgen.Tc.aff2">Department of Human Genetics<break/>McGill University<break/>Montreal, Quebec</aff>
      <aff id="androgen.Tc.aff3">Lady Davis Institute for Medical Research<break/>Department of Endocrinology<break/>Jewish General Hospital</aff>
      <aff id="androgen.Tc.aff4">Department of Medicine<break/>McGill University <break/>Montreal, Quebec</aff>
      <pub-history>
        <date date-type="created">
          <day>24</day>
          <month>3</month>
          <year>1999</year>
        </date>
        <date date-type="updated">
          <day>11</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="acpp" document-type="chapter">Andersen-Tawil Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="angelman" document-type="chapter">Angelman Syndrome</related-object>
      <abstract id="androgen.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Androgen insensitivity syndrome (AIS) is typically characterized by evidence of feminization (i.e., undermasculinization) of the external genitalia at birth, abnormal secondary sexual development in puberty, and infertility in individuals with a 46,XY karyotype. AIS represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete androgen insensitivity syndrome (CAIS), with typical female external genitalia</p>
            </list-item>
            <list-item>
              <p>Partial androgen insensitivity syndrome (PAIS) with predominantly female, predominantly male, or ambiguous external genitalia</p>
            </list-item>
            <list-item>
              <p>Mild androgen insensitivity syndrome (MAIS) with typical male external genitalia</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of AIS is established in an individual with a 46,XY karyotype who has undermasculinization of the external genitalia, impaired spermatogenesis with otherwise normal testes, absent or rudimentary m&#x000fc;llerian structures, evidence of normal or increased synthesis of testosterone and its normal conversion to dihydrotestosterone, and normal or increased luteinizing hormone (LH) production by the pituitary gland AND/OR by the identification of a hemizygous pathogenic variant in <italic toggle="yes">AR</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> To prevent testicular malignancy, treatment of CAIS may include either removal of the testes after puberty when feminization is complete or prepubertal gonadectomy accompanied by estrogen replacement therapy. Because the risk of malignancy is low, however, removal of gonads is increasingly controversial. Additional treatment for CAIS may include vaginal dilatation to avoid dyspareunia. Treatment of PAIS in individuals with predominantly female genitalia is similar to treatment of CAIS, but is more likely to include prepubertal gonadectomy to help avoid increasing clitoromegaly at the time of puberty. In individuals with PAIS and ambiguous or predominantly male genitalia, the tendency has been for parents and healthcare professionals to assign sex of rearing after an expert evaluation has been completed. Those individuals with PAIS who are raised as males may undergo urologic surgery such as orchiopexy and hypospadias repair. Those individuals with PAIS who are raised as females and who undergo gonadectomy after puberty may need combined estrogen and androgen replacement therapy. Males with MAIS may require mammoplasty for gynecomastia. A trial of androgen pharmacotherapy may help improve virilization in infancy. It is best if the diagnosis of AIS is explained to the affected individual and family in an empathic environment, with both professional and family support.</p>
          <p><italic toggle="yes">Prevention of secondary manifestations:</italic> Regular weight-bearing exercises and supplemental calcium and vitamin D are recommended to optimize bone health; bisphosphonate therapy may be indicated for those with evidence of decreased bone mineral density and/or multiple fractures.</p>
          <p><italic toggle="yes">Surveillance</italic>: Periodic reevaluation for gynecomastia during puberty in individuals assigned a male sex; monitoring of bone mineral density through DEXA scanning in adults.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> For an apparently asymptomatic older or younger sib who has normal external female genitalia and who has not yet undergone menarche, a karyotype can be done first. For those phenotypic females who have a 46,XY karyotype, molecular genetic testing for the known <italic toggle="yes">AR</italic> variant in the family can be pursued next. If the <italic toggle="yes">AR</italic> variant in the family is not known, androgen binding assays could be considered.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>AIS is inherited in an X-linked manner. Affected 46,XY individuals are almost always infertile. Each offspring of a female known to carry an <italic toggle="yes">AR</italic> pathogenic variant (heterozygote) is at a 25% risk for each of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Having a 46,XY karyotype and being affected</p>
            </list-item>
            <list-item>
              <p>Having a 46,XY karyotype and being unaffected</p>
            </list-item>
            <list-item>
              <p>Having a 46,XX karyotype and being a carrier</p>
            </list-item>
            <list-item>
              <p>Having a 46,XX karyotype and not being a carrier</p>
            </list-item>
          </list>
          <p>Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="androgen.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="androgen.Td" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_androgen.Td_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Androgen Insensitivity Syndrome: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_androgen.Td_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Complete androgen insensitivity syndrome (CAIS)</p></list-item><list-item><p>Partial androgen insensitivity syndrome (PAIS)</p></list-item><list-item><p>Mild androgen insensitivity syndrome (MAIS)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="androgen.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="androgen.TF.d.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="androgen.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="androgen.Diagnosis">
        <title>Diagnosis</title>
        <p>No formal diagnostic criteria for identifying AIS have as yet been published; large variance is seen at the molecular, biochemical, and morphologic levels due to the extreme variation in these characteristics with the various AIS phenotypes [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>].</p>
        <sec id="androgen.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Androgen insensitivity syndrome (AIS) <bold>should be suspected</bold> in an individual with the following clinical, family history, radiologic, and supportive laboratory findings.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Absence of extragenital abnormalities</p>
            </list-item>
            <list-item>
              <p>Two nondysplastic testes</p>
            </list-item>
            <list-item>
              <p>Absent or rudimentary m&#x000fc;llerian structures (i.e., fallopian tubes, uterus, and cervix) and the presence of a short vagina</p>
            </list-item>
            <list-item>
              <p>Undermasculinization of the external genitalia at birth</p>
            </list-item>
            <list-item>
              <p>Impaired spermatogenesis and/or somatic virilization (some degree of impaired virilization at puberty)</p>
            </list-item>
          </list>
          <p><bold>Family history</bold> of other affected individuals related to each other in a pattern consistent with X-linked inheritance. &#x0201c;Other affected family members&#x0201d; refers to:</p>
          <list list-type="bullet">
            <list-item>
              <p>Affected 46,XY individuals;</p>
            </list-item>
            <list-item>
              <p>Manifesting heterozygous females (46,XX). About 10% of heterozygous females have asymmetric distribution and sparse or delayed growth of pubic and/or axillary hair.</p>
            </list-item>
          </list>
          <p>Note: Absence of a family history of AIS or suggestive features of AIS does not preclude the diagnosis.</p>
          <p><bold>Radiology findings</bold> in the &#x0201c;predominantly male&#x0201d; phenotype (<xref ref-type="table" rid="androgen.T.classification_of_ais_phenoty">Table 2</xref>) including impaired development of the prostate and of the wolffian duct derivatives demonstrated by ultrasonography or genitourography</p>
          <p>
            <bold>Supportive laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Normal 46,XY karyotype</p>
            </list-item>
            <list-item>
              <p>Evidence of normal or increased synthesis of testosterone (T) by the testes</p>
            </list-item>
            <list-item>
              <p>Evidence of normal conversion of testosterone to dihydrotestosterone (DHT)</p>
            </list-item>
            <list-item>
              <p>Evidence of normal or increased luteinizing hormone (LH) production by the pituitary gland</p>
            </list-item>
            <list-item>
              <p>In CAIS, but not in PAIS: possible reduction in postnatal (0-3 months) surge in serum LH and serum T concentrations [<xref ref-type="bibr" rid="androgen.REF.bouvattier.2002.29">Bouvattier et al 2002</xref>]</p>
            </list-item>
            <list-item>
              <p>In the &#x0201c;predominantly male&#x0201d; phenotype (<xref ref-type="table" rid="androgen.T.classification_of_ais_phenoty">Table 2</xref>):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Less than normal decline of sex hormone-binding globulin in response to a standard dose of the anabolic androgen, stanozolol [<xref ref-type="bibr" rid="androgen.REF.sinnecker.1997.7">Sinnecker et al 1997</xref>]</p>
                </list-item>
                <list-item>
                  <p>Higher than normal levels of anti-m&#x000fc;llerian hormone during the first year of life or after puberty has begun</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="androgen.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of AIS <bold>is established</bold> in a 46,XY proband:</p>
          <list list-type="bullet">
            <list-item>
              <p>With undermasculinization of the external genitalia, impaired spermatogenesis with otherwise normal testes, absent or rudimentary m&#x000fc;llerian structures, evidence of normal or increased synthesis of testosterone and its normal conversion to dihydrotestosterone, and normal or increased LH production by the pituitary gland; AND/OR</p>
            </list-item>
            <list-item>
              <p>By the identification of a hemizygous pathogenic variant in <italic toggle="yes">AR</italic> by molecular genetic testing (see <xref ref-type="table" rid="androgen.T.molecular_genetic_testing_use">Table 1</xref>).</p>
            </list-item>
          </list>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">AR</italic> is performed first. Gene targeted deletion/duplication analysis to detect multiexon or whole-gene deletions or duplications may be considered if a pathogenic variant in <italic toggle="yes">AR</italic> is not identified by sequence analysis.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">AR</italic> and other genes of interest (see <xref ref-type="sec" rid="androgen.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">AR</italic>) fails to confirm a diagnosis in an individual with features of AIS. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="androgen.T.molecular_genetic_testing_use" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Androgen Insensitivity Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of 46,XY Probands w/a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">AR</italic>
                  </td>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~95%-97%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted<break/>deletion/duplication<break/>analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~3%-5%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>7</sup>
<list list-type="bullet"><list-item><p>CAIS: 65%-95%&#x000a0;<sup>5,&#x000a0;8</sup></p></list-item><list-item><p>PAIS: &#x0003c;50%&#x000a0;<sup>5,&#x000a0;8</sup></p></list-item><list-item><p>MAIS: Unknown</p></list-item></list>
</td>
                  <td headers="hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_2 hd_h_androgen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" colspan="2" align="left" rowspan="1">See footnotes 6, 7, and 8</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>CAIS = complete androgen insensitivity syndrome</p>
              </fn>
              <fn>
                <p>PAIS = partial androgen insensitivity syndrome</p>
              </fn>
              <fn>
                <p>MAIS = mild androgen insensitivity syndrome</p>
              </fn>
              <fn id="androgen.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="androgen" object-id="androgen.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="androgen.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="androgen.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="androgen.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="androgen.TF.1.4">
                <label>4. </label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation requires additional testing by gene-targeted deletion/duplication analysis.</p>
              </fn>
              <fn id="androgen.TF.1.5">
                <label>5. </label>
                <p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca">androgendb.mcgill.ca</ext-link>; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hgmd.org">www.hgmd.org</ext-link></p>
              </fn>
              <fn id="androgen.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="androgen.TF.1.7">
                <label>7. </label>
                <p><italic toggle="yes">AR</italic> pathogenic variant detection frequency in individuals with MAIS is more difficult to assess because of the assumption that MAIS diagnoses are often missed: (1) In the presence of deficient or defective androgen binding activity in genital skin fibroblasts in an XY individual with clinical findings of CAIS and PAIS, the likelihood of finding a pathogenic variant in the androgen binding domain of <italic toggle="yes">AR</italic> approached 40% [<xref ref-type="bibr" rid="androgen.REF.weidemann.1996.733">Weidemann et al 1996</xref>]. (2) In the presence of normal androgen binding in genital skin fibroblasts in an XY individual with clinical findings of PAIS, the likelihood of finding an AIS-causing <italic toggle="yes">AR</italic> variant is 10% or less, even when exon 1 is screened and/or sequenced in its entirety [Author, personal observation]. (3) Because the presence of an <italic toggle="yes">AR</italic> pathogenic variant, not abnormal androgen binding, is now the primary diagnostic criterion for AIS, defective androgen binding activity in an XY individual with clinical findings of CAIS, PAIS, or MAIS who does not have an <italic toggle="yes">AR</italic> pathogenic variant may be inappropriately precluded from the above diagnostic categories [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>, <xref ref-type="bibr" rid="androgen.REF.lek.2014.358">Lek et al 2014</xref>, <xref ref-type="bibr" rid="androgen.REF.mongan.2015.569">Mongan et al 2015</xref>]. Indeed, it has now been suggested that a new category of 46,XY disorder of sex development be established, in which no <italic toggle="yes">AR</italic> variant is found, although <italic toggle="yes">AR</italic> binding may be impaired [<xref ref-type="bibr" rid="androgen.REF.lek.2014.358">Lek et al 2014</xref>]. However, this would appear to be premature in light of the discovery of a number of cases of somatic mosaicism and intra-tissue genetic heterogeneity [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>].</p>
              </fn>
              <fn id="androgen.TF.1.8">
                <label>8. </label>
                <p>An informal survey of AIS databases in Canada, United States, and Great Britain showed that <italic toggle="yes">AR</italic> pathogenic variant detection frequency ranged from 65% to 95% in individuals with CAIS and from 40% to 45% in those with PAIS. The AIS database at the Lady Davis Institute for Medical Research (Montreal, Canada), which includes <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.androgendb.mcgill.ca/ldi.pdf">138 individuals with CAIS or PAIS</ext-link>, reflects this variable detection rate [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>]. Indeed, two additional reports have revealed a substantial percentage of individuals with putative PAIS in whom no <italic toggle="yes">AR</italic> variant has been found [<xref ref-type="bibr" rid="androgen.REF.veigajunior.2012">Veiga-Junior et al 2012</xref>, <xref ref-type="bibr" rid="androgen.REF.lek.2014.358">Lek et al 2014</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Androgen binding assay.</bold> If molecular genetic testing fails to identify a pathogenic variant that can explain the affected individual&#x02019;s phenotype, testing of a biopsy of genital skin for defective androgen binding may be considered. As a result of the increasing number of individuals with features of PAIS in whom no pathogenic A<italic toggle="yes">R</italic> variant is able to be identified, there has been an increase in demand for androgen binding assays to confirm the diagnosis of AIS.</p>
        </sec>
      </sec>
      <sec id="androgen.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="androgen.Clinical_Description">
          <title>Clinical Description</title>
          <p>Androgen insensitivity syndrome (AIS) can be subdivided into three phenotypes: complete androgen insensitivity syndrome (CAIS), partial androgen insensitivity syndrome (PAIS), and mild androgen insensitivity syndrome (MAIS) (<xref ref-type="table" rid="androgen.T.classification_of_ais_phenoty">Table 2</xref>).</p>
          <table-wrap id="androgen.T.classification_of_ais_phenoty" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Classification of AIS Phenotypes</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Type</th>
                  <th id="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">External Genitalia (Synonyms)</th>
                  <th id="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Findings</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>CAIS</bold>
                  </td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Female (&#x0201c;testicular feminization&#x0201d;)</td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Absent OR rudimentary wolffian duct derivatives</p></list-item><list-item><p>Absence or presence of epididymides and/or vas deferens</p></list-item><list-item><p>Inguinal, labial, or abdominal testes</p></list-item><list-item><p>Short blind-ending vagina</p></list-item><list-item><p>Scant OR absent pubic AND/OR axillary hair</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>PAIS</bold>
                  </td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Predominantly female (&#x0201c;incomplete AIS&#x0201d;)</td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Inguinal OR labial testes</p></list-item><list-item><p>Clitoromegaly and labial fusion</p></list-item><list-item><p>Distinct urethral and vaginal openings OR a urogenital sinus</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Ambiguous</td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Microphallus (&#x0003c;1 cm) with clitoris-like underdeveloped glans; labia majora-like bifid scrotum</p></list-item><list-item><p>Descended OR undescended testes</p></list-item><list-item><p>Perineoscrotal hypospadias OR urogenital sinus</p></list-item><list-item><p>Gynecomastia (development of breasts) in puberty</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Predominantly male</td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Simple (glandular or penile) OR severe (perineal) &#x0201c;isolated&#x0201d; hypospadias with a normal-sized penis and descended testes OR severe hypospadias with micropenis, bifid scrotum, and either descended OR undescended testes</p></list-item><list-item><p>Gynecomastia in puberty</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>MAIS</bold>
                  </td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Male (&#x0201c;undervirilized male syndrome&#x0201d;)</td>
                  <td headers="hd_h_androgen.T.classification_of_ais_phenoty_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Impaired spermatogenesis AND/OR impaired pubertal virilization</p></list-item><list-item><p>Gynecomastia in puberty</p></list-item></list>
</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Adapted from <xref ref-type="bibr" rid="androgen.REF.sinnecker.1997.7">Sinnecker et al [1997]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Complete androgen insensitivity syndrome (CAIS).</bold> Individuals with CAIS have normal female external genitalia with absence of female internal genitalia. They typically present either before puberty with masses in the inguinal canal that are subsequently identified as testes or at puberty with primary amenorrhea and sparse to absent pubic or axillary hair. Breasts and female adiposity develop normally. Sexual identity and orientation are typically female and heterosexual.</p>
          <p>CAIS almost always runs true in families; that is, affected XY relatives usually have normal female external genitalia and seldom have any sign of external genital masculinization, such as clitoromegaly or posterior labial fusion [<xref ref-type="bibr" rid="androgen.REF.boehmer.2001.4151">Boehmer et al 2001</xref>]. On occasion, wolffian duct development is observed [<xref ref-type="bibr" rid="androgen.REF.hannema.2004.5815">Hannema et al 2004</xref>].</p>
          <p><bold>Partial AIS (PAIS) with predominantly female external genitalia</bold> presents in a manner similar to CAIS; however, affected individuals have signs of external genital masculinization including clitoromegaly or posterior labial fusion.</p>
          <p><bold>Partial AIS with ambiguous genitalia or predominantly male genitalia (PAIS, Reifenstein syndrome).</bold> Determining the sex of rearing may be an issue for children with frank genital ambiguity. In families with PAIS, phenotypic disparity may warrant male sex of rearing in one affected sib and female sex of rearing in another affected sib [<xref ref-type="bibr" rid="androgen.REF.boehmer.2001.4151">Boehmer et al 2001</xref>, <xref ref-type="bibr" rid="androgen.REF.chen.2015.373">Chen et al 2015</xref>]. Individuals with PAIS and predominantly male genitalia are raised as males. Gynecomastia at puberty and impaired spermatogenesis occur in all individuals with PAIS. Pubic hair is usually moderate; facial, body, and axillary hair are often reduced.</p>
          <p><bold>Mild AIS (MAIS, undervirilized male syndrome).</bold> The external genitalia of affected individuals are unambiguously male. They usually present with gynecomastia at puberty. They may have undermasculinization that includes sparse facial and body hair and small penis. Impotence may be a complaint. Spermatogenesis may or may not be impaired. In some instances, the only observed abnormality appears to be male infertility [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2005.42">Gottlieb et al 2005</xref>]; therefore, MAIS could explain some cases of idiopathic male infertility [<xref ref-type="bibr" rid="androgen.REF.goglia.2011.1165">Goglia et al 2011</xref>].</p>
          <p>MAIS almost always runs true in families.</p>
        </sec>
        <sec id="androgen.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>A correlation does exist among certain missense <italic toggle="yes">AR</italic> variants, their functional consequences, and external genital development, particularly in the case of CAIS (see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/">Androgen Receptor Gene Mutations Database</ext-link>).</p>
          <p>The correlation is much less clear in PAIS, in which interfamilial phenotypic variation is observed [<xref ref-type="bibr" rid="androgen.REF.brinkmann.2000.317">Brinkmann &#x00026; Trapman 2000</xref>, <xref ref-type="bibr" rid="androgen.REF.boehmer.2001.4151">Boehmer et al 2001</xref>, <xref ref-type="bibr" rid="androgen.REF.deeb.2005.56">Deeb et al 2005</xref>, <xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>, <xref ref-type="bibr" rid="androgen.REF.lek.2014.358">Lek et al 2014</xref>].</p>
          <p>The Androgen Receptor Gene Mutations Database includes <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/variable.pdf">45 instances</ext-link> in which identical <italic toggle="yes">AR</italic> variants produce different AIS phenotypes [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2001a.382">Gottlieb et al 2001a</xref>, <xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>].</p>
          <p>In some instances, the variable expressivity associated with a number of single-nucleotide variants may be attributed to somatic mosaicism rather than to the modifying influence of &#x0201c;background&#x0201d; genetic factors [<xref ref-type="bibr" rid="androgen.REF.boehmer.1997.1003">Boehmer et al 1997</xref>, <xref ref-type="bibr" rid="androgen.REF.holterhus.1997.3584">Holterhus et al 1997</xref>, <xref ref-type="bibr" rid="androgen.REF.holterhus.2001.627">Holterhus et al 2001</xref>, <xref ref-type="bibr" rid="androgen.REF.k_hler.2005.106">K&#x000f6;hler et al 2005</xref>]. See <xref ref-type="bibr" rid="androgen.REF.gottlieb.2001b.79">Gottlieb et al [2001b]</xref> for a detailed discussion of the possible role of somatic mosaicism as a cause of variable expressivity.</p>
          <p>It remains to be determined whether specific missense variants can be correlated with normal or impaired spermatogenesis and with absence or presence of localized expressions of undervirilization (e.g., gynecomastia, high-pitched voice, impotence). Although specific variants associated with azoospermia have been reported [<xref ref-type="bibr" rid="androgen.REF.zuccarello.2008.580">Zuccarello et al 2008</xref>, <xref ref-type="bibr" rid="androgen.REF.mirfakhraie.2011.367">Mirfakhraie et al 2011</xref>], only a more extensive analysis of more cases of idiopathic male infertility is likely to identify definitive correlations. <xref ref-type="bibr" rid="androgen.REF.melo.2010.128">Melo et al [2010]</xref> noted that infertile males who do not produce sperm have a higher number of <italic toggle="yes">AR</italic> variants than do males with impaired sperm production. Idiopathic infertility cases were found in both oligospermic and azoospermic men who had <italic toggle="yes">AR</italic>-CAG repeat lengths that were either significantly shorter (15-18 CAG repeat lengths) or significantly longer (22-28) than normal (i.e., 19-21); see <xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al [2012]</xref> and <xref ref-type="bibr" rid="androgen.REF.giagulli.2014.689">Giagulli et al [2014]</xref>.</p>
        </sec>
        <sec id="androgen.Penetrance">
          <title>Penetrance</title>
          <p>No definitive data regarding penetrance exist, possibly because of under-ascertainment of affected individuals, particularly phenotypic but infertile males in whom <italic toggle="yes">AR</italic> molecular genetic testing may not be performed [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2005.42">Gottlieb et al 2005</xref>]. The problem is compounded by situations where there is a genotype-phenotype disconnect and when individuals with features of AIS are not found to have an identifiable <italic toggle="yes">AR</italic> pathogenic variant.</p>
        </sec>
        <sec id="androgen.Nomenclature">
          <title>Nomenclature</title>
          <p>The terms "testicular feminization" and androgen resistance syndrome are outdated and thus rarely used now.</p>
        </sec>
        <sec id="androgen.Prevalence">
          <title>Prevalence</title>
          <p>Standard references quote a prevalence of 2:100,000 to 5:100,000 for complete AIS (CAIS) based on estimates derived from otherwise healthy phenotypic females found to have histologically normal inguinal or abdominal testes. A survey in the Netherlands over a ten-year period based on reported cases of AIS concluded that the minimal incidence was 1:99,000 [<xref ref-type="bibr" rid="androgen.REF.boehmer.2001.4151">Boehmer et al 2001</xref>].</p>
          <p>Partial AIS (PAIS) is at least as common as CAIS.</p>
          <p>The prevalence of mild AIS (MAIS) has not yet been determined. However, it is much less frequently reported than CAIS and PAIS [<xref ref-type="bibr" rid="androgen.REF.hughes.2012">Hughes et al 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="androgen.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Expansion of the polymorphic CAG trinucleotide repeat within <italic toggle="yes">AR</italic> causes <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">spinal and bulbar muscular atrophy</related-object> (SBMA; Kennedy disease).</p>
        <p>See <xref ref-type="sec" rid="androgen.Molecular_Genetics">Molecular Genetics</xref>, <bold>Somatic <italic toggle="yes">AR</italic> alterations and cancer</bold> for other disease conditions associated with somatic alterations to AR.</p>
      </sec>
      <sec id="androgen.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/277000">277000</ext-link>) is diagnosed in phenotypic females who exhibit amenorrhea and have a partial or complete absence of the cervix, uterus, and vagina. Individuals with MRKH can be distinguished from those with CAIS by confirmation of a 46,XX karyotype [<xref ref-type="bibr" rid="androgen.REF.sultan.2009.8">Sultan et al 2009</xref>].</p>
        <p><bold>Hypospadias</bold> resulting from an <italic toggle="yes">AR</italic> pathogenic variant (and thus a part of the spectrum of PAIS) cannot be distinguished from hypospadias resulting from other (largely undefined) causes by the examination of the genitalia alone. <italic toggle="yes">AR</italic> variants associated with hypospadias are likely rare.</p>
        <p><bold>MAIS</bold> caused by single-nucleotide variants of <italic toggle="yes">AR</italic> [<xref ref-type="bibr" rid="androgen.REF.wang.1998.4303">Wang et al 1998</xref>] may be clinically indistinguishable from MAIS caused by expansion of the polymorphic CAG repeat in <italic toggle="yes">AR</italic> [<xref ref-type="bibr" rid="androgen.REF.tut.1997.3777">Tut et al 1997</xref>]. Pathogenic expansion of this triplet repeat is the cause of <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">spinal and bulbar muscular atrophy</related-object> (SBMA), also known as Kennedy disease (see <xref ref-type="sec" rid="androgen.Genetically_Related_Allelic_Dis">Genetically Related Disorders</xref>).</p>
        <p><bold>Undermasculinization of the external genitalia and pubertal undervirilization</bold> are components of many different syndromes that have no etiologic relation to <italic toggle="yes">AR</italic>. They may or may not have a pathogenic relation to the androgen receptor protein. The one exception is a contiguous gene deletion syndrome that includes the <italic toggle="yes">AR</italic> locus and results in intellectual disability and genital abnormalities [<xref ref-type="bibr" rid="androgen.REF.davies.1997.158">Davies et al 1997</xref>].</p>
        <p><bold>46,XY infants born small for gestational age</bold> may have clinical features of PAIS with no identifiable <italic toggle="yes">AR</italic> pathogenic variant. It has been suggested that this association be termed &#x02018;XY DSD with fetal growth restriction, as yet unexplained&#x02019; [<xref ref-type="bibr" rid="androgen.REF.lek.2014.358">Lek et al 2014</xref>].</p>
        <p>A <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.androgendb.mcgill.ca/ldi.pdf">survey</ext-link> of the Androgen Receptor Gene Mutations Database suggests that AIS may be attributable to factors other than the presence of <italic toggle="yes">AR</italic> variants. Findings that suggest the presence of other identifiable diagnoses in 46,XY individuals with predominantly female, ambiguous, or predominantly male genitalia include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Elevated levels of testosterone precursors caused by a partial testosterone biosynthetic defect in which compensatory serum LH concentrations stimulate a normal plasma testosterone concentration</p>
          </list-item>
          <list-item>
            <p>The presence of m&#x000fc;llerian duct derivatives as a result of a testicular organogenesis defect with impaired Sertoli cell production of anti-m&#x000fc;llerian hormone</p>
          </list-item>
          <list-item>
            <p>The presence of wolffian duct-derived internal male reproductive structures that differentiate in response to testosterone, suggesting 5-&#x003b1;-reductase deficiency, a partial testosterone biosynthetic defect, or PAIS. 5-&#x003b1;-reductase deficiency (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/264600">264600</ext-link>) is the result of biallelic pathogenic variants in <italic toggle="yes">SRD5A2</italic>. The enzyme converts testosterone to dihydrotestosterone (DHT), which is primarily responsible for the development of the external genitalia before birth.</p>
          </list-item>
          <list-item>
            <p>A recent study has reported that some individuals with features of PAIS have been found to have biallelic pathogenic variants in <italic toggle="yes">HSD17B3</italic>, which causes 17-beta hydroxysteroid dehydrogenase III deficiency (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/264300">264300</ext-link>) [<xref ref-type="bibr" rid="androgen.REF.phelan.2015.745">Phelan et al 2015</xref>].</p>
          </list-item>
        </list>
        <p>Issues to consider in individuals with some, but not all, of the clinical features of AIS:</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal serum concentrations of T, DHT, and LH after birth do not prove that the concentration was normal during the critical period of fetal genital masculinization.</p>
          </list-item>
          <list-item>
            <p>Normal responsiveness to androgen after birth does not prove that it was normal before birth. That is, in utero delay in the acquisition of normal androgen biosynthesis or normal androgen sensitivity may lead to features consistent with androgen insensitivity.</p>
          </list-item>
          <list-item>
            <p>Subnormal sensitivity to androgen after birth may involve components of the overall androgen response system (AR-interacting proteins) beyond the androgen receptor itself.</p>
          </list-item>
        </list>
      </sec>
      <sec id="androgen.Management">
        <title>Management</title>
        <sec id="androgen.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and the needs of an individual diagnosed with androgen insensitivity syndrome, a complete evaluation by specialists in disorders of sex development (DSDs), which can include specialists in endocrinology, urology, gynecology, clinical genetics, psychology, and psychiatry [<xref ref-type="bibr" rid="androgen.REF.hughes.2006.554">Hughes et al 2006</xref>, <xref ref-type="bibr" rid="androgen.REF.parisi.2007.348">Parisi et al 2007</xref>, <xref ref-type="bibr" rid="androgen.REF.douglas.2010">Douglas et al 2010</xref>], is ideal.</p>
        </sec>
        <sec id="androgen.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A number of clinicians have sought to establish a consensus statement on management of DSD including AIS [<xref ref-type="bibr" rid="androgen.REF.hughes.2006.577">Hughes &#x00026; Deeb 2006</xref>]. A number of publications have subsequently discussed best management of these disorders. See <xref ref-type="bibr" rid="androgen.REF.diamond.2008">Diamond &#x00026; Beh [2008]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/nrendo/journal/v4/n1/full/ncpendmet0694.html">full text</ext-link>), <xref ref-type="bibr" rid="androgen.REF.douglas.2010">Douglas et al [2010]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ijpeonline.com/content/2010/1/919707">full text</ext-link>), <xref ref-type="bibr" rid="androgen.REF.pasterski.2010">Pasterski et al [2010]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S1521690X09001456">full text</ext-link>), <xref ref-type="bibr" rid="androgen.REF.wiesemann.2010">Wiesemann et al [2010]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859219/?tool=pubmed">full text</ext-link>), and <xref ref-type="bibr" rid="androgen.REF.hughes.2012">Hughes et al [2012]</xref> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0140673612600713">full text</ext-link>).</p>
          <p><bold>Assignment of sex of rearing.</bold> The issue of sex assignment in infancy when the child is being evaluated for ambiguous genitalia is paramount. It requires informed decision making by parents and healthcare personnel and should be resolved as early as possible, after a multidisciplinary evaluation has been completed.</p>
          <list list-type="bullet">
            <list-item>
              <p>Even in CAIS this may not always be easy. <xref ref-type="bibr" rid="androgen.REF.cheikhelard.2008.1496">Cheikhelard et al [2008]</xref> evaluated 29 individuals with CAIS; it was recommended that gonads be retained at least until the completion of spontaneous puberty and the possibility of virilization be evaluated before management decisions are made.</p>
            </list-item>
            <list-item>
              <p>Psychological counseling and use of support groups can be of benefit [<xref ref-type="bibr" rid="androgen.REF.cull.2010.310">Cull &#x00026; Simmonds 2010</xref>, <xref ref-type="bibr" rid="androgen.REF.hughes.2012">Hughes et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Gender identity has become a topic of increasing importance due to the possibility of changes in sex assignment over time [<xref ref-type="bibr" rid="androgen.REF.kolesinska.2014.e710">Kolesinska et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>Issues of sexual orientation regardless of gender phenotype have also become increasingly important to explore and discuss [<xref ref-type="bibr" rid="androgen.REF.brunner.2016.109">Brunner et al 2016</xref>].</p>
            </list-item>
          </list>
          <sec id="androgen.CAIS">
            <title>CAIS</title>
            <p>A critical consideration of any surgical intervention is the nature and timing of such intervention; thus, surgeons need to be involved with the affected individuals and pediatrician in any such decisions [<xref ref-type="bibr" rid="androgen.REF.purves.2008.1716">Purves et al 2008</xref>, <xref ref-type="bibr" rid="androgen.REF.munoz.2010.188">Munoz &#x00026; Swan 2010</xref>]. <xref ref-type="bibr" rid="androgen.REF.vidal.2010.311">Vidal et al [2010]</xref> reviewed the evolution of surgical techniques for &#x02018;feminization&#x02019; and &#x02018;masculinization&#x02019; and their possible outcomes.</p>
            <p>A common practice is to remove the testes after puberty when feminization of the affected individual is complete, since feminization occurs partly by testicular estrogen and partly by peripheral conversion of androgen to estrogen.</p>
            <p>The rationale for postpubertal gonadectomy is that testicular malignancy, which develops at the usual rate for cryptorchid testes, seldom occurs before puberty [<xref ref-type="bibr" rid="androgen.REF.hannema.2006.518">Hannema et al 2006</xref>]. Prepubertal gonadectomy is now only considered if inguinal testes are physically or esthetically uncomfortable, and if inguinal herniorrhaphy is necessary. In this event, estrogen replacement therapy is necessary to initiate puberty, maintain feminization, and avoid osteoporosis.</p>
            <p>However, the issue of gonadectomy is controversial. Some have argued that the true risk for malignant transformation of the gonads is small and have suggested postpubertal gonad biopsy as opposed to removal [<xref ref-type="bibr" rid="androgen.REF.hughes.2006.554">Hughes et al 2006</xref>, <xref ref-type="bibr" rid="androgen.REF.parisi.2007.348">Parisi et al 2007</xref>, <xref ref-type="bibr" rid="androgen.REF.patel.2016.320">Patel et al 2016</xref>], which would allow affected individuals to retain a natural source of androgen production and avoid exogenous hormone replacement.</p>
            <p>In one study of 48 individuals diagnosed with either CAIS or PAIS, gonadoblastomas were observed in 9/30 (30%) of individuals with CAIS and 3/18 (16%) of individuals with PAIS, suggesting that the risk of gonadal malignancy may be greater than previously reported; the authors suggest earlier rather than later prophylactic gonadectomy [<xref ref-type="bibr" rid="androgen.REF.liu.2014.1413">Liu et al 2014</xref>]. Another study found the frequency of gonadal tumor in individuals with CAIS was 13/48 (27%) and in those with PAIS was 2/21 (9%), with similar conclusions regarding the time of gonadectomy [<xref ref-type="bibr" rid="androgen.REF.jiang.2016.338">Jiang et al 2016</xref>].</p>
            <p>Vaginal dilatation to augment vaginal length and to avoid dyspareunia is typically the treatment of choice for those with short vaginal length. If this method fails, new treatments of blind vagina have been proposed, including autologous buccal mucosal graft vaginoplasty and enhanced balloon vaginoplasty [<xref ref-type="bibr" rid="androgen.REF.zhao.2009.645">Zhao et al 2009</xref>, <xref ref-type="bibr" rid="androgen.REF.el_saman.2011.779">El Saman et al 2011</xref>]. Recent studies that examined the long-term outcomes of vaginoplasty with autologous buccal micromucosa indicated a high degree of satisfaction [<xref ref-type="bibr" rid="androgen.REF.li.2014.951">Li et al 2014</xref>]. In addition, a study reported that peritoneal vaginoplasty appeared to be superior to ileal vaginoplasty [<xref ref-type="bibr" rid="androgen.REF.huang.2014.691">Huang et al 2014</xref>]. However, surgical reconstruction frequently requires maintenance vaginal dilatation to decrease the likelihood of future stricture.</p>
            <p>The question of how much and when to disclose the diagnosis of CAIS to an affected individual has not been resolved uniformly; however, it has become obvious that explanation of the diagnosis in an empathic setting is much preferable to systematic concealment or self-discovery of the diagnosis in an environment devoid of support from family, professionals, and other affected individuals [<xref ref-type="bibr" rid="androgen.REF.conn.2005.628">Conn et al 2005</xref>].</p>
          </sec>
          <sec id="androgen.PAIS_with_Predominantly_Female">
            <title>PAIS with Predominantly Female Genitalia (Incomplete AIS)</title>
            <p>The issues are similar to those discussed under CAIS, except prepubertal gonadectomy helps avoid the emotional discomfort of increasing clitoromegaly at the time of puberty.</p>
            <p>In instances in which the diagnosis of PAIS is difficult to establish because of the presence of somatic mosaicism, a change of sex assignment can result in concomitant problems [<xref ref-type="bibr" rid="androgen.REF.k_hler.2005.106">K&#x000f6;hler et al 2005</xref>].</p>
          </sec>
          <sec id="androgen.PAIS_with_Ambiguous_Genitalia_o">
            <title>PAIS with Ambiguous Genitalia or Predominantly Male Genitalia</title>
            <p>The assignment of sex in an infant with ambiguous genitalia is a complex process that requires timely assessment by a multidisciplinary team in consultation with the family and should be resolved as early as possible. Aside from purely anatomic and surgical considerations, the choice of a male sex-of-rearing demands a therapeutic trial with pharmacologic doses of androgen to try to predict potential androgen responsiveness at puberty. Furthermore, appreciable phallic growth in response to administered androgen facilitates reconstructive surgery.</p>
            <p>In instances in which maximum information is being gathered on an infant with no family history of AIS before sex is assigned, sequence analysis of <italic toggle="yes">AR</italic> may be considered; however, the lower probability of detecting an <italic toggle="yes">AR</italic> variant in individuals with the PAIS phenotype and the poor positive predictive value of any given variant regarding AIS phenotype need to be considered when making decisions about sex assignment.</p>
            <p>It has also been reported that the length of the <italic toggle="yes">AR</italic> exon 1 CAG repeat can influence the efficacy of testosterone treatments: individuals with shorter repeat lengths are more likely to respond to hormonal treatments [<xref ref-type="bibr" rid="androgen.REF.zitzmann.2009.1341">Zitzmann 2009</xref>]. However, the efficacy of CAG repeat length as a possible marker to assess hormonal treatment must await further studies.</p>
            <p>Based on experience with a small number of individuals, the role of long-term androgen pharmacotherapy in individuals with PAIS who are raised as males remains unclear. Response to androgen treatment may be substantial in individuals with certain missense variants in the DNA-binding domain of the androgen receptor [<xref ref-type="bibr" rid="androgen.REF.weidemann.1998.1173">Weidemann et al 1998</xref>], and a recent study confirmed the difficulty of accurately predicting the efficacy of androgen treatment [<xref ref-type="bibr" rid="androgen.REF.becker.2016.173">Becker et al 2016</xref>]. Thus, considerable caution should be exercised with regard to androgen treatment [<xref ref-type="bibr" rid="androgen.REF.werner.2010.263">Werner et al 2010</xref>], in particular because special hormonal profiles to androgen insensitivity have often not been acknowledged in replacement strategies. It has been proposed that an external masculinization score in neonates could be a reasonable predictor of virilization at puberty in individuals with PAIS who have been assigned a male sex of rearing [<xref ref-type="bibr" rid="androgen.REF.hughes.2012">Hughes et al 2012</xref>].</p>
            <p>Gynecomastia that develops in puberty eventually requires reduction mammoplasty. It has been reported that tamoxifen has been used for treating pubertal gynecomastia in two sibs with PAIS [<xref ref-type="bibr" rid="androgen.REF.saito.2014.211">Saito et al 2014</xref>].</p>
            <p>Those individuals with PAIS who are raised as females and who have gonadectomy after puberty may need combined estrogen and androgen replacement therapy, the latter to maintain libido.</p>
          </sec>
          <sec id="androgen.MAIS">
            <title>MAIS</title>
            <p>Men with MAIS often require reduction mammoplasty for treatment of gynecomastia.</p>
            <p>A trial of androgen pharmacotherapy is recommended to attempt to improve virilization [<xref ref-type="bibr" rid="androgen.REF.loy.2001.315">Loy &#x00026; Yong 2001</xref>].</p>
          </sec>
        </sec>
        <sec id="androgen.Prevention_of_Primary_Manifesta">
          <title>Prevention of Primary Manifestations</title>
          <p>The efficacy of androgen therapy in preventing manifestations such as gynecomastia is not clear.</p>
        </sec>
        <sec id="androgen.Prevention_of_Secondary_Manifes">
          <title>Prevention of Secondary Manifestations</title>
          <p>Women with CAIS have decreased bone mineral density, regardless of timing of gonadectomy [<xref ref-type="bibr" rid="androgen.REF.oakes.2008.305">Oakes et al 2008</xref>]. However, women with PAIS who choose not to undergo gonadectomy do not appear to be at high risk for decreased bone mineral density [<xref ref-type="bibr" rid="androgen.REF.bertelloni.2010.270">Bertelloni et al 2010</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>In addition to estrogen replacement therapy, supplemental calcium and vitamin D are recommended.</p>
            </list-item>
            <list-item>
              <p>Regular weight-bearing exercises are encouraged to maintain bone health.</p>
            </list-item>
            <list-item>
              <p>Bisphosphonate therapy may be indicated for those individuals with evidence of decreased bone mineral density and/or multiple fractures.</p>
            </list-item>
          </list>
        </sec>
        <sec id="androgen.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate measures include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Monitoring of postnatal development of genitalia that were ambiguous at birth for changes that could lead to reconsideration of the assigned sex</p>
            </list-item>
            <list-item>
              <p>For individuals assigned a male sex, evaluation during puberty for signs of gynecomastia</p>
            </list-item>
            <list-item>
              <p>In adults, monitoring of bone mineral density through DEXA (dual-emission x-ray absorptiometry) scanning [<xref ref-type="bibr" rid="androgen.REF.oakes.2008.305">Oakes et al 2008</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="androgen.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate the apparently asymptomatic older and younger sibs of a proband in order to identify as early as possible those who would benefit from institution of treatment and preventive measures.</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluations can include karyotype in sibs who have normal external female genitalia but have not yet undergone menarche.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing can be pursued next if a phenotypic female is found to have a 46,XY karyotype and if the <italic toggle="yes">AR</italic> variant in the family is known.</p>
            </list-item>
            <list-item>
              <p>Androgen binding assays may be considered if an <italic toggle="yes">AR</italic> variant has not been identified in the family.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="androgen.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="androgen.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="androgen.Other">
          <title>Other</title>
          <p><xref ref-type="bibr" rid="androgen.REF.chen.2010.27776">Chen et al [2010]</xref> noted that Fkbp52 regulates AR transactivation activity and male urethra morphogenesis, suggesting that <italic toggle="yes">AR</italic> variants may require other genetic factors to produce hypospadias.</p>
          <p>Apolipoprotein D (APOD) is a possible biomarker of AR function in AIS [<xref ref-type="bibr" rid="androgen.REF.appari.2009.623">Appari et al 2009</xref>].</p>
        </sec>
      </sec>
      <sec id="androgen.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="androgen.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Androgen insensitivity syndrome (AIS) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="androgen.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a 46,XY proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband will not have the disorder nor will he be hemizygous for the <italic toggle="yes">AR</italic> pathogenic variant; therefore, he does not require further evaluation/testing.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate heterozygote (carrier). If a woman has more than one affected child and the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>If the proband is the only affected family member (i.e., a simplex case) several possibilities exist regarding the carrier status of the mother:</p>
              <list list-type="bullet">
                <list-item>
                  <p>The mother is heterozygous for an <italic toggle="yes">AR</italic> pathogenic variant; in 22 of 30 simplex families with CAIS or PAIS, the mother was proven to be heterozygous for an <italic toggle="yes">AR</italic> pathogenic variant [<xref ref-type="bibr" rid="androgen.REF.hiort.1998.939">Hiort et al 1998</xref>].</p>
                </list-item>
                <list-item>
                  <p>The mother has germline mosaicism or somatic and germline mosaicism for an <italic toggle="yes">AR</italic> pathogenic variant [<xref ref-type="bibr" rid="androgen.REF.boehmer.1997.1003">Boehmer et al 1997</xref>; <xref ref-type="bibr" rid="androgen.REF.k_hler.2005.106">K&#x000f6;hler et al 2005</xref>].</p>
                </list-item>
                <list-item>
                  <p>The mother is not a carrier and the pathogenic variant occurred <italic toggle="yes">de novo</italic> in the proband; <italic toggle="yes">de novo</italic> pathogenic variants can be expected to occur approximately 30% of the time [<xref ref-type="bibr" rid="androgen.REF.hughes.2006.577">Hughes &#x00026; Deeb 2006</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Sibs of a 46,XY proband.</bold> The risk to the sibs depends on the carrier status of the mother:</p>
          <list list-type="bullet">
            <list-item>
              <p>If the mother of the proband has an <italic toggle="yes">AR</italic> pathogenic variant, the chance of transmitting it in each pregnancy is 50%.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sibs with a 46,XY karyotype who inherit the <italic toggle="yes">AR</italic> pathogenic variant will be affected.</p>
                </list-item>
                <list-item>
                  <p>Sibs with a 46,XX karyotype who inherit the <italic toggle="yes">AR</italic> pathogenic variant will be carriers.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the proband represents a simplex case (i.e., a single occurrence in a family) and if the <italic toggle="yes">AR</italic> pathogenic variant cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal germline mosaicism [<xref ref-type="bibr" rid="androgen.REF.boehmer.1997.1003">Boehmer et al 1997</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a 46,XY proband.</bold> Individuals with a 46,XY karyotype who have any of the subtypes of AIS (i.e., CAIS, PAIS, MAIS) are almost always infertile.</p>
          <p>
            <bold>Offspring of a heterozygous (carrier) female</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each offspring of a female known to be a carrier of an <italic toggle="yes">AR</italic> pathogenic variant carrier (heterozygote) has a 25% likelihood of each of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Having a 46,XY karyotype and being affected</p>
                </list-item>
                <list-item>
                  <p>Having a 46,XY karyotype and being unaffected</p>
                </list-item>
                <list-item>
                  <p>Having a 46,XX karyotype and being a carrier</p>
                </list-item>
                <list-item>
                  <p>Having a 46,XX karyotype and not being a carrier</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>The phenotype of offspring with a 46,XY karyotype and CAIS or MAIS tends to be fairly predictable. The genital phenotype of individuals with PAIS within a family is generally consistent; however, a wide range of phenotypic variability is seen among families who share the same PAIS pathogenic variant, making it difficult to predict the phenotype in a simplex case.</p>
            </list-item>
          </list>
        </sec>
        <sec id="androgen.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Female carriers may be identified through one or a combination of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Molecular genetic testing.</bold> Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the pathogenic variant has been identified in the proband. If an affected family member is not available for testing, molecular genetic testing can be offered first by sequence analysis, and if no pathogenic variant is identified, by gene-targeted deletion/duplication analysis.</p>
              <p>Note: Inability to detect a pathogenic variant in <italic toggle="yes">AR</italic> in an at-risk female relative when the proband is not available for genetic testing does not preclude carrier status.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Family history</bold>
              </p>
            </list-item>
            <list-item>
              <p><bold>Clinical findings.</bold> Ten percent of carriers are manifesting carriers with asymmetric distribution and sparse or delayed growth of pubic or axillary hair, a finding that results from random X-chromosome inactivation. The presence of normal pubic and axillary hair does not rule out the possibility that an individual with a 46,XX karyotype is a carrier.</p>
            </list-item>
          </list>
        </sec>
        <sec id="androgen.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="androgen.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><xref ref-type="bibr" rid="androgen.REF.cohenkettenis.2010.325">Cohen-Kettenis [2010]</xref> reviews some similarities in relevant psychosocial and psychosexual issues associated with gender dysphoria in people with disorders of sex development (DSDs) and those with who do not have a DSD. Because few studies focusing on the psychosocial and psychosexual issues in individuals with DSDs have been completed, <xref ref-type="bibr" rid="androgen.REF.cohenkettenis.2010.325">Cohen-Kettenis [2010]</xref> suggests that clinicians working with individuals and families with DSDs consider relying on the literature related to individuals with gender dysphoria who do not have a DSD.</p>
          <p><bold>Gender identity.</bold> In a long-term outcome study of DSDs that included CAIS, it was noted that while many affected individuals fare well, dissatisfaction with original gender assignment has been underestimated and gender and sexual counseling should be part of the multidisciplinary service available to individuals with DSDs [<xref ref-type="bibr" rid="androgen.REF.warne.2008.268">Warne 2008</xref>].</p>
          <p>Of particular interest is a case report of an individual with CAIS with male gender identity [<xref ref-type="bibr" rid="androgen.REF.tsjoen.2011.635">Tsjoen et al 2011</xref>]. More recently, another individual with CAIS who has a male gender identity was reported; this individual has a sib with CAIS who had female central precocious puberty [<xref ref-type="bibr" rid="androgen.REF.berm_dez_de_la_vega.2015.75">Berm&#x000fa;dez de la Vega et al 2015</xref>]. Further insight into issues of gender identity in persons with CAIS is available from analysis of accounts presented by an XY female on the UK <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.aissg.org/41_STORIES.HTM#Adult">AIS Support Group Web site</ext-link> [<xref ref-type="bibr" rid="androgen.REF.garrett.2009.428">Garrett &#x00026; Kirkman 2009</xref>].</p>
          <p>An additional ethical and possibly legal issue is the genetic testing of other family members for AIS. In a 1999 court decision (unrelated to AIS) chromosome findings alone were used to determine an individual&#x02019;s sex. Clinicians should be aware that information provided to individuals with AIS and their families (in the interest of facilitating appropriate medical care) could potentially have legal implications for such individuals/families [<xref ref-type="bibr" rid="androgen.REF.berg.2007.434">Berg et al 2007</xref>].</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="androgen.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>High-risk pregnancy.</bold> Once the <italic toggle="yes">AR</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible options.</p>
          <p><bold>Pregnancies not known to be at increased risk for AIS.</bold> Prenatal diagnosis of AIS in pregnancies not known to have been at risk have been published. In two cases, diagnosis of AIS was suspected after discordance in sex identified by ultrasonography (female) and karyotype (46,XY) was found [<xref ref-type="bibr" rid="androgen.REF.yalinkaya.2007.856">Yalinkaya et al 2007</xref>, <xref ref-type="bibr" rid="androgen.REF.bianca.2009.167">Bianca et al 2009</xref>]. In another report, cell-free fetal DNA obtained using noninvasive prenatal screening found the presence of Y chromosome material in a fetus with female external genitalia by ultrasound. A subsequent amniocentesis revealed the presence of a pathogenic <italic toggle="yes">AR</italic> variant, which resulted in a diagnosis of AIS [<xref ref-type="bibr" rid="androgen.REF.zilberman.2015.114">Zilberman et al 2015</xref>].</p>
          <p>Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="androgen.Resources">
        <title>Resources</title>
      </sec>
      <sec id="androgen.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">AR</italic> comprises nine exons. Nucleotide numbering is complicated by the length of the variable polyglutamine and polyglycine repeats (see <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">Kennedy Disease</related-object>). A reference sequence must be specified when naming variants in <italic toggle="yes">AR</italic>.</p>
        <p>For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="androgen" object-id="androgen.molgen.TA">Table A</related-object>, <bold>Gene</bold>. See also <bold>Normal gene product</bold>.</p>
        <p>Coincidentally, two major species of <italic toggle="yes">AR</italic> mRNA (10-11 kb; ~7 kb) result from alternative splicing of a very long 3'-UTR. Two forms of the androgen receptor protein (A and B) exist. Their size difference suggests that the short form (B) represents translation initiation at the internal p.Met190 residue.</p>
        <p>Note: The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/">Androgen Receptor Gene Mutations Database</ext-link> has recently changed its nucleotide and amino acid numbering scheme to conform to the HGVS standards, which are based on NCBI cDNA reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000044.2">NM_000044.2</ext-link>.</p>
        <p><bold>Pathogenic variants.</bold> More than 550 single-nucleotide variants in <italic toggle="yes">AR</italic> have been found to cause AIS (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/">Androgen Receptor Gene Mutations Database</ext-link>). The great majority are missense variants that impair DNA or androgen binding and cause CAIS or PAIS; a small number have been proven to cause MAIS.</p>
        <p>Single-nucleotide variants in exon 1 are relatively uncommon; the majority of variants are either nonsense or small deletions or insertions that result in a frameshift; thus, they almost always cause CAIS; PAIS is seldom the result of exon 1 variants [<xref ref-type="bibr" rid="androgen.REF.choong.1996.1423">Choong et al 1996</xref>]. That said, the number of single-nucleotide variants identified in exon 1 has increased over the past few years; a considerable number are associated with the MAIS phenotype (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/">Androgen Receptor Gene Mutations Database</ext-link>).</p>
        <p>A relatively small number of <italic toggle="yes">AR</italic> deletions/duplications of one or more exons or of the whole gene have been described (see <related-object source-id="gene" document-id="androgen" object-id="androgen.molgen.TA">Table A</related-object>, <bold>Locus Specific</bold>). In almost all cases when an attempt has been made to test these variant forms of androgen receptor protein, they have been found to be nonfunctional.</p>
        <p>Expansion of the trinucleotide repeat tract (CAG)<sub>n</sub>CAA that encodes a polyglutamine tract to more than 38 repeats results in <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">Kennedy disease</related-object> (spinal and bulbar muscular atrophy) with some findings of MAIS, which are likely the result of the reduced transactivation of <italic toggle="yes">AR</italic> with long CAG repeat tracts of androgen receptor proteins that contain expanded polyglutamine tracts.</p>
        <p><bold>Normal gene product.</bold> Androgen receptor. The entire N-terminal portion of the androgen receptor (~538 amino acids) is encoded by exon 1, the DNA-binding domain (amino acid residues 558-617) by exons 2 and 3, the bipartite nuclear localization signal (amino acid residues 618-637) by exons 3 and 4, and the androgen-binding domain (residues 646-920) by exons 4-8.</p>
        <p>Two forms of the androgen receptor protein (A and B) are produced by the alternative splice forms of <italic toggle="yes">AR</italic> (see <bold>Gene structure</bold>). Their size difference suggests that the short form (B) represents translation initiation at the internal p.Met190 residue.</p>
        <p>The androgen receptor is a well-defined transcriptional regulatory factor. Once activated by binding to androgen, it collaborates with other co-regulatory proteins (some involve DNA binding, others do not) to achieve control over the rate of transcription of an androgen target gene that is under the influence of a nearby promoter. A large number of AR-associated proteins have now been identified [<xref ref-type="bibr" rid="androgen.REF.heinlein.2002.175">Heinlein &#x00026; Chang 2002</xref>, <xref ref-type="bibr" rid="androgen.REF.gottlieb.2004b.527">Gottlieb et al 2004b</xref>, <xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>]; for latest listing see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://androgendb.mcgill.ca/ARinteract.pdf">Androgen Receptor Gene Mutations Database</ext-link>.</p>
        <p><bold>Abnormal gene product.</bold> Nearly all single-nucleotide variants in the androgen-binding domain impair androgen binding and impair transactivation by the AR. Some decrease only the apparent equilibrium affinity constant; some increase only the non-equilibrium dissociation rate; others do both, either with all androgens or selectively with certain androgens. Still others are thermolabile or degrade excessively in the presence of androgen. Single-nucleotide variants in the zinc fingers or &#x003b1;-helical portions of the DNA-binding domain impair binding to a sequence of regulatory nucleotides known as an androgen response element. Such binding is essential for the androgen receptor to exert transcriptional regulatory control over most of its target genes.</p>
        <p>The effect of specific variants on the functionality of the androgen receptor has been studied using molecular dynamic modeling based on the x-ray crystal structure [<xref ref-type="bibr" rid="androgen.REF.matias.2000.26164">Matias et al 2000</xref>]. This technique has successfully simulated the effects of particular variants on the ligand-binding properties of mutated androgen receptors [<xref ref-type="bibr" rid="androgen.REF.wu.2003.465">Wu et al 2003</xref>, <xref ref-type="bibr" rid="androgen.REF.elhaji.2004.1876">Elhaji et al 2004</xref>, <xref ref-type="bibr" rid="androgen.REF.elhaji.2006.921">Elhaji et al 2006</xref>]. It is hoped that this technique may eventually lead to treatments that return to normal the ligand-binding capacity of mutated androgen receptors.</p>
        <p><bold>Somatic <italic toggle="yes">AR</italic> alterations and cancer.</bold> Some cancers show somatic alterations in <italic toggle="yes">AR.</italic> These, however, appear to result in a gain of function rather than the loss of function seen in AIS. Cancers include the following [<xref ref-type="bibr" rid="androgen.REF.gottlieb.2004a.121">Gottlieb et al 2004a</xref>, <xref ref-type="bibr" rid="androgen.REF.gottlieb.2012.887">Gottlieb et al 2012</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prostate cancer</p>
          </list-item>
          <list-item>
            <p>Male breast cancer</p>
          </list-item>
          <list-item>
            <p>Laryngeal cancer</p>
          </list-item>
          <list-item>
            <p>Liver cancer</p>
          </list-item>
          <list-item>
            <p>Testicular cancer</p>
          </list-item>
          <list-item>
            <p>Bladder cancer [<xref ref-type="bibr" rid="androgen.REF.rahmani.2013.150">Rahmani et al 2013</xref>]</p>
          </list-item>
        </list>
      </sec>
      <sec id="androgen.References">
        <title>References</title>
        <sec id="androgen.Published_GuidelinesConsensus_S">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="androgen.Published_GuidelinesConsensus_S.reflist0">
            <ref id="androgen.REF.diamond.2008">
              <mixed-citation publication-type="web">Diamond M, Beh HG. Changes in the management of children with intersex conditions. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/nrendo/journal/v4/n1/full/ncpendmet0694.html">online</ext-link>. 2008. Accessed 5-8-17.</mixed-citation>
            </ref>
            <ref id="androgen.REF.douglas.2010">
              <mixed-citation publication-type="web">Douglas G, Axelrad ME, Brandt ML, Crabtree E, Dietrich JE, French S, Gunn S, Karaviti L, Lopez ME, Macias CG, McCullough LB, Suresh D, Sutton VR. Consensus in guidelines for evaluation of DSD by the Texas Children&#x02019;s Hospital multidisciplinary gender medicine team. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ijpeonline.com/content/2010/1/919707">online</ext-link>. 2010. Accessed 5-8-17.</mixed-citation>
            </ref>
            <ref id="androgen.REF.hughes.2012">
              <mixed-citation publication-type="web">Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannapoulou K, MacDougall J. Androgen Insensitivity Syndrome. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0140673612600713">online</ext-link>. 2012. Accessed 5-8-17.</mixed-citation>
            </ref>
            <ref id="androgen.REF.pasterski.2010">
              <mixed-citation publication-type="web">Pasterski V, Prentice P, Hughes IA. Impact of the consensus statement and the new DSD classification system. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S1521690X09001456">online</ext-link>. 2010. Accessed 5-8-17.</mixed-citation>
            </ref>
            <ref id="androgen.REF.wiesemann.2010">
              <mixed-citation publication-type="web">Wiesemann C, Ude-Koeller S, Sinnecker GH, Thyen U. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859219/?tool=pubmed">online</ext-link>. 2010. Accessed 5-8-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="androgen.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="androgen.Literature_Cited.reflist0">
            <ref id="androgen.REF.appari.2009.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Appari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wunsch</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cario</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demeter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieppe</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.</article-title>
                <source>J Mol Med</source>
                <volume>87</volume>
                <fpage>623</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">19330472</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.becker.2016.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wain</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gosai</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milburn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stott</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>BJ</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) bfore, during and after puberty &#x02013; a case series.</article-title>
                <source>J Pediatr Endocrinol Metab</source>
                <volume>29</volume>
                <fpage>173</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">26352087</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.berg.2007.434">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCullogh</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleppe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunn</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaviti</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Ethical and legal implications of genetic testing in androgen insensitivity syndrome</article-title>
                <source>J Pediatr</source>
                <volume>150</volume>
                <fpage>434</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17382127</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.berm_dez_de_la_vega.2015.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berm&#x000fa;dez de la Vega</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Cancio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aud&#x000ed;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Complete androgen insensitivity syndrome associated with male gender identity or female precocious puberty in the same family.</article-title>
                <source>Sex Dev</source>
                <volume>9</volume>
                <fpage>75</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25633053</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.bertelloni.2010.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertelloni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baroncelli</surname>
                    <given-names>GI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Bone health in disorders of sex differentiation.</article-title>
                <source>Sex Dev</source>
                <volume>4</volume>
                <fpage>270</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">20820111</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.bianca.2009.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bianca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cataliotti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartoloni</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torrente</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrano</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boemi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo Presti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Indaco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ettore</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Prenatal diagnosis of androgen insensitivity syndrome.</article-title>
                <source>Fetal Diagn Ther</source>
                <volume>26</volume>
                <fpage>167</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19844078</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.boehmer.2001.4151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boehmer</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruggenwirth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Assendelft</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otten</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verleun-Mooijman</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niermeijer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouwe</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waelkens</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostdijk</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kwast</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vroede</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drop</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genotype versus phenotype in families with androgen insensitivity syndrome.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>86</volume>
                <fpage>4151</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11549642</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.boehmer.1997.1003">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boehmer</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niermeijer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halley</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drop</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling.</article-title>
                <source>Am J Hum Genet</source>
                <volume>60</volume>
                <fpage>1003</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9106550</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.bouvattier.2002.29">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouvattier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carel</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecointre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sultan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaussain</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>87</volume>
                <fpage>29</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">11788616</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.brinkmann.2000.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trapman</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Genetic analysis of androgen receptors in development and disease.</article-title>
                <source>Adv Pharmacol</source>
                <volume>47</volume>
                <fpage>317</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">10582090</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.brunner.2016.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fliegner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krupp</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rall</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brucker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richter-Appelt</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Gender role, gender identity and sexual orientation in CAIS (&#x0201c;XY-Women&#x0201d;) compared with subfertile and infertile 46,XX,women.</article-title>
                <source>J Sex Res</source>
                <volume>53</volume>
                <fpage>109</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">26133743</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.cheikhelard.2008.1496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cheikhelard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibaud</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lotat-Jacob</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaubert</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nihoul-Fekete</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Long-term follow up and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity</article-title>
                <source>J Urol</source>
                <volume>180</volume>
                <fpage>1496</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">18710728</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.chen.2010.27776">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinds</surname>
                    <given-names>TD</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shou</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Fkbp52 regulates androgen receptor transactivation activity and male urethra morphogenesis.</article-title>
                <source>J Biol Chem</source>
                <volume>285</volume>
                <fpage>27776</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">20605780</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.chen.2015.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelrad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietrich</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gargollo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macias</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCullough</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roth</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaviti</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Androgen insensitivity syndrome: management considerations from infancy to adulthood.</article-title>
                <source>Pediatr Endocrinol Rev</source>
                <volume>12</volume>
                <fpage>373</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">26182482</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.choong.1996.1423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choong</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quigley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.</article-title>
                <source>J Clin Invest</source>
                <volume>98</volume>
                <fpage>1423</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">8823308</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.cohenkettenis.2010.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen-Kettenis</surname>
                    <given-names>PT</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Psychosocial and pycholsexual aspects of disorders of sex development.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>24</volume>
                <fpage>325</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">20541155</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.conn.2005.628">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillam</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>GS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Revealing the diagnosis of androgen insensitivity syndrome in adulthood.</article-title>
                <source>BMJ</source>
                <volume>331</volume>
                <fpage>628</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16166136</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.cull.2010.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cull</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmonds</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Importance of support groups for intersex (disorders of sexual development) patients, families and the medical profession.</article-title>
                <source>Sex Dev</source>
                <volume>4</volume>
                <fpage>310</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">20606384</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.davies.1997.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quigley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinsky</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MN</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Androgen insensitivity with mental retardation: a contiguous gene syndrome?</article-title>
                <source>J Med Genet</source>
                <volume>34</volume>
                <fpage>158</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">9039995</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.deeb.2005.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deeb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mason</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>63</volume>
                <fpage>56</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">15963062</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.diamond.2008.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diamond</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beh</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Changes in the management of children with intersex conditions.</article-title>
                <source>Nat Clin Pract Endocrinol Metab</source>
                <volume>4</volume>
                <fpage>4</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17984980</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.douglas.2010.919707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelrad</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crabtree</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietrich</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>French</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karaviti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macias</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCullough</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suresh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Consensus in guidelines for evaluation of DSD by the Texas Children&#x02019;s Hospital multidisciplinary gender medicine team.</article-title>
                <source>Int J Pediatr Endocrinol</source>
                <volume>2010</volume>
                <fpage>919707</fpage>
                <pub-id pub-id-type="pmid">20981291</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.elhaji.2006.921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elhaji</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoica</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Purisima</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.</article-title>
                <source>Hum Mol Genet</source>
                <volume>15</volume>
                <fpage>921</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">16449235</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.elhaji.2004.1876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elhaji</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarado</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batist</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.</article-title>
                <source>Mol Endocrinol</source>
                <volume>18</volume>
                <fpage>1876</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">15118070</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.el_saman.2011.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>El Saman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ismael</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zakherah</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nasr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tawfik</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedaiwy</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Enhancement balloon vaginoplasty for treatment of blind vagina due to androgen insensitivity.</article-title>
                <source>Fertil Steril</source>
                <volume>95</volume>
                <fpage>779</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">21055746</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.garrett.2009.428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Being an XY female: an analysis of accounts from the website of the androgen insensitivity syndrome support group.</article-title>
                <source>Health Care Women Int</source>
                <volume>30</volume>
                <fpage>428</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">19350438</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.giagulli.2014.689">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giagulli</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbone</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Pergola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guastamacchia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Resta</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchelli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabb&#x000e0;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triggiani</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility?</article-title>
                <source>J Assist Reprod Genet.</source>
                <year>2014</year>
                <volume>31</volume>
                <fpage>689</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">24691874</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.goglia.2011.1165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goglia</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinanzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuccarello</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malpassi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ameri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minuto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fioresta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferone</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Identification of a novel mutation in exon 1 of the androgen receptor gene in an azoospermic patient with mild androgen insensitivity syndrome: case report and literature review.</article-title>
                <source>Fertil Steril</source>
                <volume>96</volume>
                <fpage>1165</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21962961</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2001a.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Variable expressivity and mutation databases: the androgen receptor gene mutations database.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>382</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11317353</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2001b.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Somatic mosaicism and variable expressivity.</article-title>
                <source>Trends Genet</source>
                <volume>17</volume>
                <fpage>79</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11173116</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2004a.121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elhaji</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Nuclear receptors and disease: androgen receptor.</article-title>
                <source>Essays Biochem</source>
                <volume>40</volume>
                <fpage>121</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15242343</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2004b.527">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>The androgen receptor gene mutations database (ARDB): 2004 update.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>527</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15146455</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2012.887">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadarajah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paliouras</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>The androgen receptor gene mutations database (ARDB): 2012 update.</article-title>
                <source>Hum Mutat</source>
                <volume>33</volume>
                <fpage>887</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">22334387</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.gottlieb.2005.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lumbroso</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular pathology of the androgen receptor in male (in)fertility.</article-title>
                <source>Reprod Biomed Online</source>
                <volume>10</volume>
                <fpage>42</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15705293</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hannema.2004.5815">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hannema</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodapp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwabe</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>89</volume>
                <fpage>5815</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15531547</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hannema.2006.518">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hannema</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajpert-De Meyts</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skakkebaek</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Testicular development in the complete androgen insensitivity syndrome.</article-title>
                <source>J Pathol.</source>
                <volume>208</volume>
                <fpage>518</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">16400621</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.heinlein.2002.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heinlein</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Androgen receptor (AR) coregulators: an overview.</article-title>
                <source>Endocr Rev</source>
                <volume>23</volume>
                <fpage>175</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">11943742</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hiort.1998.939">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinnecker</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitsche</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruse</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Inherited and de novo androgen receptor gene mutations: investigation of single-case families.</article-title>
                <source>J Pediatr</source>
                <volume>132</volume>
                <fpage>939</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">9627582</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.holterhus.2001.627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruggenwirth</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Post-zygotic mutations and somatic mosaicism in androgen insensitivity syndrome.</article-title>
                <source>Trends Genet</source>
                <volume>17</volume>
                <fpage>627</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11672858</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.holterhus.1997.3584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruggenwirth</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleinkauf-Houcken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruse</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinnecker</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>82</volume>
                <fpage>3584</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9360511</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.huang.2014.691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Comparison of improved laproscopic peritoneal vaginoplasty and gasless laproscopic ileal vaginoplasty in treatment of androgen insensitivity syndrome.</article-title>
                <source>Arch Gynecol Obstet</source>
                <volume>290</volume>
                <fpage>691</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24838288</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hughes.2012.1419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunch</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasterski</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastroyannapoulou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDougall</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Androgen insensitivity syndrome.</article-title>
                <source>Lancet.</source>
                <volume>380</volume>
                <fpage>1419</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">22698698</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hughes.2006.577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deeb</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Androgen resistance.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>20</volume>
                <fpage>577</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">17161333</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.hughes.2006.554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houk</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Consensus statement on management of intersex disorders.</article-title>
                <source>Arch Dis Child</source>
                <volume>91</volume>
                <fpage>554</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16624884</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.jiang.2016.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>QJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Gonad malignancy in 202 female patients with disorders of sex development containing Y-chromosome material.</article-title>
                <source>Gynecol Endocrinol</source>
                <volume>32</volume>
                <fpage>338</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">26608236</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.k_hler.2005.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;hler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lumbroso</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audran</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grau</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurtz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semitcheva</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czernichow</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sultan</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>90</volume>
                <fpage>106</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">15522944</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.kolesinska.2014.e710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kolesinska</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmed</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedziela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryce</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molinska-Gur</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinnott</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darendeliler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zwan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cools</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guran</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertelloni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lisa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arlt</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krone</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellaithi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balsamo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenstrom</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachlan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkhawari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatelain</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weintrob</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Changes over time in sex assignments for disorders of sex development.</article-title>
                <source>Pediatrics</source>
                <volume>134</volume>
                <fpage>e710</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25092939</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.lek.2014.358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lek</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilfold-Wilkie</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadoroko-Cuccaro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Low frequency of androgen receptor gene mutations in 46XY DSD, and fetal growth restriction.</article-title>
                <source>Arch Dis Child</source>
                <volume>99</volume>
                <fpage>358</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">24366239</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.li.2014.951">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Longterm outcomes of vaginoplasty with autologous buccal micromucosa.</article-title>
                <source>Obstet Gynecol</source>
                <volume>123</volume>
                <fpage>951</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24785845</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.liu.2014.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>AX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>ZJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences.</article-title>
                <source>Hum Reprod</source>
                <volume>29</volume>
                <fpage>1413</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24826988</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.loy.2001.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Loy</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Sex, infertility and the molecular biology of the androgen receptor.</article-title>
                <source>Curr Opin Obstet Gynecol</source>
                <volume>13</volume>
                <fpage>315</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11396657</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.matias.2000.26164">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matias</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomaz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peixoto</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macedo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joschko</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wegg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schafer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrondo</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>26164</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">10840043</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.melo.2010.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Melo</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daninb</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tacon</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moura</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>da Cruz</surname>
                    <given-names>AD</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Association between malre infertility and androgen receptor mutations in Brazilian patients.</article-title>
                <source>Genet Mol Res</source>
                <volume>9</volume>
                <fpage>128</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">20198568</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.mirfakhraie.2011.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirfakhraie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalantar</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirzajani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montazeri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salsabili</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houshmand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashemi-Gorji</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourmand</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A novel mutation in the transactivation-regulating domain of the androgen receptor in a patient with azoospermia.</article-title>
                <source>J Androl.</source>
                <volume>32</volume>
                <fpage>367</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">21127309</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.mongan.2015.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mongan</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadokoro-Cuccaro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Androgen insensitivity syndrome.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>29</volume>
                <fpage>569</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">26303084</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.munoz.2010.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swan</surname>
                    <given-names>KG</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Disorders of sexual differentiation: surgical challenges of vaginal reconstruction in complete androgen insensitivity syndrome.</article-title>
                <source>Am Surg</source>
                <volume>76</volume>
                <fpage>188</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">20336898</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.oakes.2008.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oakes</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyvazzadeh</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quint</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>YR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Complete androgen insensitivity syndrome &#x02013; a review.</article-title>
                <source>J Pediatr Adolesc Gynecol</source>
                <volume>21</volume>
                <fpage>305</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">19064222</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.parisi.2007.348">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parisi</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsdell</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grady</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunther</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kletter</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCauley</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opheim</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihoker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soules</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagon</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A gender assessment team: experience with 250 patients over a period of 25 years.</article-title>
                <source>Genet Med</source>
                <volume>9</volume>
                <fpage>348</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">17575501</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.pasterski.2010.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasterski</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prentice</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>IA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Impact of the consensus statement and the new DSD classification system.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>24</volume>
                <fpage>187</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">20541147</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.patel.2016.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez-Lobo</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Timing of gonadectomy in patients with complete androgen insensitivity syndrome- current recommendations and future directions.</article-title>
                <source>J Pediatr Adolesc Gynecol</source>
                <volume>29</volume>
                <fpage>320</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">26428189</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.phelan.2015.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phelan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardamone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creighton</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumsby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>GS</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Screening for mutations in 17&#x003b2;-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46,XY disorders of sex development.</article-title>
                <source>Eur J Endocrinol</source>
                <volume>172</volume>
                <fpage>745</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">25740850</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.purves.2008.1716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Purves</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miles-Thomas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Migeon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gearhart</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Complete androgen insensitivity:the role of the surgeon.</article-title>
                <source>J Urol</source>
                <volume>180</volume>
                <fpage>1716</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18715581</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.rahmani.2013.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rahmani</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alzohairy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babiker</surname>
                    <given-names>AYY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aly</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizvi</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Implication of androgen receptor in urinary bladder cancer:a critical mini review.</article-title>
                <source>Int J Mol Epidemiol Genet</source>
                <volume>4</volume>
                <fpage>150</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24046807</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.saito.2014.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawagoe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusuhara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukami</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Tamoxifen treatment for pubertal gynecomastia in two siblings with partial androgen insensitivity syndrome.</article-title>
                <source>Horm Res Paediatr.</source>
                <year>2014</year>
                <volume>81</volume>
                <fpage>211</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24577144</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.sinnecker.1997.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sinnecker</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitsche</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruse</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group.</article-title>
                <source>Eur J Pediatr</source>
                <volume>156</volume>
                <fpage>7</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">9007482</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.sultan.2009.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sultan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biason-Lauber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philibert</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mayer-Rokitansky-Kuster-Hauser syndrome: Recent clinical and genetic findings.</article-title>
                <source>Gynecol Endocrinol</source>
                <volume>25</volume>
                <fpage>8</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19165657</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.tsjoen.2011.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsjoen</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Cuypere</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monstrey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoebeke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freedman</surname>
                    <given-names>FK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holterhus</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Borsel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cools</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Male gender identity in complete androgen insensitivity syndrome.</article-title>
                <source>Arch Sex Behav.</source>
                <year>2011</year>
                <volume>40</volume>
                <fpage>635</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20358272</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.tut.1997.3777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tut</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadessy</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinsky</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>82</volume>
                <fpage>3777</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">9360540</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.veigajunior.2012">
              <mixed-citation publication-type="other">Veiga-Junior NN, Medaets PA, Petroli RJ, Calais FL, de Mello MP, Castro CC, Guaragna-Filho G, Sewaybricker LE, Marques-de-Faria AP, Maciel-Guerra AT, Guerra-Junior G. Clinical and laboratorial features that may differentiate 46,XY DSD due to partial androgen insensitivity and 5&#x003b1;-reductase type 2 deficiency. Int J Endocrinol. 2012;2012:964876.</mixed-citation>
            </ref>
            <ref id="androgen.REF.vidal.2010.311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vidal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorduza</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haraux</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gay</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatelain</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mure</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouriquand</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Surgical optons in disorders of sex development (dsd) with ambiguous genitalia.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab.</source>
                <volume>24</volume>
                <fpage>311</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">20541154</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.wang.1998.4303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghadessy</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trounson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Kretser</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLachlan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans-activation.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>83</volume>
                <fpage>4303</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9851768</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.warne.2008.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warne</surname>
                    <given-names>GL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Long-term outcome of disorders of sex development.</article-title>
                <source>Sex Dev</source>
                <volume>2</volume>
                <fpage>268</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">18987501</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.weidemann.1996.733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weidemann</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linck</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haupt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mentrup</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romalo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockklauser</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweikert</surname>
                    <given-names>HU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spindler</surname>
                    <given-names>KD</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>45</volume>
                <fpage>733</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9039340</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.weidemann.1998.1173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weidemann</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romalo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spindler</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweikert</surname>
                    <given-names>HU</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>83</volume>
                <fpage>1173</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9543136</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.werner.2010.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Werner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grotsch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiort</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>46-XY disorders of sex development- the undermasculinised male with disorders of androgen action.</article-title>
                <source>Best Pract Res Clin Endocrinol Metab</source>
                <volume>24</volume>
                <fpage>263</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">20541151</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.wiesemann.2010.671">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiesemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ude-Koeller</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinnecker</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thyen</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents.</article-title>
                <source>Eur J Pediatr</source>
                <volume>169</volume>
                <fpage>671</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19841941</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.wu.2003.465">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gottlieb</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batist</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sulea</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Purisima</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beitel</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiro</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2003</year>
                <volume>22</volume>
                <fpage>465</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">14635106</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.yalinkaya.2007.856">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yalinkaya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yayala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdermoglu</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prenatal diagnosis of fetus with androgen insensitivity syndrome.</article-title>
                <source>Prenat Diagn.</source>
                <volume>27</volume>
                <fpage>856</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">17605153</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.zhao.2009.645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pengcheng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senkai</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qiang</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Use of autologous micromucosa graft for vaginoplasty in vaginal agenesis.</article-title>
                <source>Ann Plast Surg</source>
                <volume>63</volume>
                <fpage>645</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19816155</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.zilberman.2015.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zilberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panrikh</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landy</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Prenatal diagnosis of androgen insensitivity syndrome using cell-free fetal DNA testing.</article-title>
                <source>Ultrasound Obstet Gynecol</source>
                <volume>45</volume>
                <fpage>114</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25291542</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.zitzmann.2009.1341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zitzmann</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pharmacogenetics of testosterone replacement therapy.</article-title>
                <source>Pharmacogenomics</source>
                <volume>10</volume>
                <fpage>1341</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19663677</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.zuccarello.2008.580">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zuccarello</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferlin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinanzi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garolla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callewaert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claessens</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brinkmann</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foresta</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>68</volume>
                <fpage>580</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17970778</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="androgen.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="androgen.Suggested_Reading.reflist0">
            <ref id="androgen.REF.bennett.2010.813">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hooper</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobe</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Molecular cell biology of androgen receptor signaling.</article-title>
                <source>Int J Biochem Cell Biol</source>
                <volume>42</volume>
                <fpage>813</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">19931639</pub-id>
              </element-citation>
            </ref>
            <ref id="androgen.REF.galani.2008.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Galani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitsiou-Tzeli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sofokelous</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanavakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalpini-Mavrou</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Androgen insensitivity syndrome: clinical features and molecular defects.</article-title>
                <source>Hormones (Athens)</source>
                <volume>7</volume>
                <fpage>217</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">18694860</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="androgen.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="androgen.Author_History">
          <title>Author History</title>
          <p>Lenore K Beitel, PhD (2004-2017) Bruce Gottlieb, PhD (2004-present) Leonard Pinsky, MD, FACMG; McGill University (1999-2004) Mark A Trifiro, MD (1999-present)</p>
        </sec>
        <sec id="androgen.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>11 May 2017 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 July 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>24 May 2007 (cd) Revision: deletion/duplication analysis available on a clinical basis</p>
            </list-item>
            <list-item>
              <p>19 September 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 April 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 December 2002 (lp) Revision: Testing</p>
            </list-item>
            <list-item>
              <p>19 November 2001 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 March 1999 (pb) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1998 (lp/mt) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
